Wang T, Smith DA, Campbell C, Mokaya J, Freeman O, Salih H, McNaughton AL, Cripps S, Vrnai KA, Noble T, Woods K, Collier J, Jeffery K, Davies J, Barnes E, Matthews PC, Hepatitis B
This article walks through what the before and after timeline actually looks like at 3, 6, and 12 months based on clinical observations from our patient population, what affects the magnitude of results, and who is the right candidate for this protocol
150 With this understanding, many pharmaceutical researchers have conjugated their bioactive compounds to lipophilic moieties in the hope that they will become sufficiently lipid soluble to passively move through the BBB
This suggests: Ongoing cellular damage from free radicals Increased inflammation throughout the body Accelerated aging at the cellular level Higher risk of chronic diseases The danger: Youre fighting a losing battle against oxidative damage, which can lead to cardiovascular disease, neurological decline, cancer, and autoimmune conditions
